A detailed history of Capstone Investment Advisors, LLC transactions in Novavax Inc stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 39,600 shares of NVAX stock, worth $370,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,600
Previous 21,600 83.33%
Holding current value
$370,260
Previous $103,000 386.41%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$3.76 - $6.02 $154,889 - $247,987
41,194 New
41,194 $196,000
Q3 2023

Nov 13, 2023

BUY
$6.81 - $9.74 $91,437 - $130,778
13,427 Added 797.33%
15,111 $109,000
Q2 2023

Aug 10, 2023

BUY
$6.67 - $9.52 $10,925 - $15,593
1,638 Added 3560.87%
1,684 $12,000
Q1 2023

May 09, 2023

BUY
$5.76 - $12.48 $264 - $574
46 New
46 $0
Q2 2022

Aug 15, 2022

SELL
$36.28 - $75.29 $101,946 - $211,564
-2,810 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$69.73 - $142.9 $195,941 - $401,549
2,810 New
2,810 $207,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.